Inotrem   Report issue

For profit Phase 2
Founded: Paris France (2013)

Organization Overview

First Clinical Trial
2016
NCT03463044
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CEO and Medical Officer | Inotrem | INOTREM SA